Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
7.76
+0.73 (10.39%)
At close: Sep 18, 2024, 4:00 PM
7.72
-0.04 (-0.45%)
After-hours: Sep 18, 2024, 7:57 PM EDT
Candel Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | 0.13 | 0.13 | 0.13 | 0.13 |
| Cost of Revenue | 21.66 | 23.98 | 20.35 | 14.59 | - | 6.61 |
| Gross Profit | -21.66 | -23.98 | -20.22 | -14.47 | 0.13 | -6.48 |
| Selling, General & Admin | 13.99 | 14.41 | 14.5 | 11.26 | 5.99 | 2.56 |
| Research & Development | - | - | - | - | 7.94 | - |
| Operating Expenses | 13.99 | 14.41 | 14.5 | 11.26 | 13.94 | 2.56 |
| Operating Income | -35.65 | -38.39 | -34.72 | -25.73 | -13.81 | -9.04 |
| Interest Expense | -2.56 | -2.6 | -1.71 | -0.05 | - | - |
| Interest & Investment Income | 1.48 | 2.08 | 1.22 | - | 0.11 | 1.07 |
| Other Non Operating Income (Expenses) | -13.26 | 0.97 | 16.42 | -10.81 | -3.98 | -0.27 |
| EBT Excluding Unusual Items | -49.99 | -37.94 | -18.79 | -36.59 | -17.68 | -8.24 |
| Other Unusual Items | - | - | - | 0.46 | - | - |
| Pretax Income | -49.99 | -37.94 | -18.79 | -36.12 | -17.68 | -8.24 |
| Net Income | -49.99 | -37.94 | -18.79 | -36.12 | -17.68 | -8.24 |
| Net Income to Common | -49.99 | -37.94 | -18.79 | -36.12 | -17.68 | -8.24 |
| Shares Outstanding (Basic) | 29 | 29 | 29 | 19 | 12 | 12 |
| Shares Outstanding (Diluted) | 29 | 29 | 29 | 19 | 12 | 12 |
| Shares Change (YoY) | 1.16% | 0.39% | 52.72% | 62.49% | 0.71% | - |
| EPS (Basic) | -1.71 | -1.31 | -0.65 | -1.91 | -1.52 | -0.71 |
| EPS (Diluted) | -1.71 | -1.31 | -0.65 | -1.91 | -1.52 | -0.71 |
| Free Cash Flow | -31.03 | -34.7 | -32.72 | -24.05 | -10.55 | -5.34 |
| Free Cash Flow Per Share | -1.06 | -1.20 | -1.14 | -1.27 | -0.91 | -0.46 |
| Gross Margin | - | - | - | - | 100.00% | - |
| Operating Margin | - | - | -27777.60% | -20580.80% | -11048.00% | -7229.60% |
| Profit Margin | - | - | -15035.20% | -28899.20% | -14144.00% | -6592.00% |
| Free Cash Flow Margin | - | - | -26172.80% | -19242.40% | -8437.60% | -4268.80% |
| EBITDA | -34.66 | -37.43 | -33.94 | -25.49 | -13.72 | -8.99 |
| D&A For EBITDA | 0.99 | 0.96 | 0.78 | 0.23 | 0.09 | 0.04 |
| EBIT | -35.65 | -38.39 | -34.72 | -25.73 | -13.81 | -9.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.